COVID-19 after lung transplantation: Four case reports

Hongyi Wang; Yixing LI; Heng Zhao; Yanpeng Zhang; Shan Gao; Jizhao Wang; Yilong Zhao; Shuo LI; Guangjian Zhang

Return

COVID-19 after lung transplantation: Four case reports

VernacularTitle:肺移植术后新型冠状病毒感染四例
Author: Hongyi WANG ^{1
,

2
,

3} ; Yixing LI ^{1
,

2
,

3} ; Heng ZHAO ^{1
,

2
,

3} ; Yanpeng ZHANG ^{1
,

2
,

3} ; Shan GAO ^{1
,

2
,

3} ; Jizhao WANG ^{1
,

2
,

3} ; Yilong ZHAO ^{1
,

2
,

3} ; Shuo LI ^{1
,

2
,

3} ; Guangjian ZHANG ^{1
,

2
,

3}
Author Information

1. Department of Thoracic Surgery, The First Affiliated Hospital of Xi'
2. an Jiaotong University, Xi'
3. an, 710061, P. R. China
Publication Type:Journal Article
Keywords: Lung transplantation; coronavirus disease 2019; immunosuppression adjustment; antiviral drug; case report
From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2024;31(11):1697-1702
CountryChina
Language:Chinese
Abstract: From December 2022 to January 2023, 4 lung transplant recipients (3 males and 1 female, aged 52-60 years, all received transplantation less than 1 year) were hospitalized in the Department of Thoracic Surgery of the First Affiliated Hospital of Xi'an Jiaotong University due to COVID-19 after surgery. The clinical manifestations were mostly characterized by elevated body temperature accompanied by shortness of breath, and indicators such as heart rate, oxygen saturation, and oxygenation index could reflect the severity of the condition. The therapy was timely adjusted to immunosuppressive drugs, upgraded oxygen therapy, anti-bacterial and anti-fungal therapy, prone ventilation, general treatment, and anticoagulant therapy, depending on the situation. Finally, 3 patients were cured and discharged from hospital, and 1 died.